Company page

Biodesix, Inc.

Biodesix, Inc. (Ticker: BDSX) is a public company based in the United States with a market capitalization of approximately $174 million. The company focuses on developing and commercializing diagnostic solutions for lung diseases. Biodesix aims to improve patient outcomes through its innovative testing technologies and personalized medicine approach.